Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 128

Sort by

Sort Order Select

Journal Articles

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Blood (2025) 146 (22): 2681–2695.

https://doi.org/10.1182/blood.2024027692

Published: 2025

Includes: Supplemental data

Journal Articles

One-year follow-up of CD19/BCMA dual-targeting fastcar-T GC012F (AZD0120) therapy in patients with refractory systemic lupus erythematosus

Jingjing Feng, Heng Cao, Mingming Zhang, Xintong Feng, Shan Fu, Guoqing Wei, Ruimin Hong, Lianjun Shen, Jin Lin, Zhihong Liu, Jia Liu, Yongxian Hu, He Huang

Blood (2025) 146 (Supplement 1): 2384.

https://doi.org/10.1182/blood-2025-2384

Published: 2025

Journal Articles

Thyroid diffuse large B-cell lymphoma in China: Multicenter study of diagnosis, clinical features, treatment efficacy, prognostic factors, and genomic alterations

Blood (2025) 146 (Supplement 1): 1902.

https://doi.org/10.1182/blood-2025-1902

Published: 2025

Journal Articles

A phase 1 study of lucar-G39D: A novel anti-CD20/CD19 dual-CAR allogeneic gamma delta T cells in adults with relapsed / refractory B-cell non-Hodgkin lymphoma (NHL)

Blood (2025) 146 (Supplement 1): 266.

https://doi.org/10.1182/blood-2025-266

Published: 2025

Journal Articles

Discrimination of Epstein–Barr virus latent infection and lytic replication reactivation using a novel methyl-CRISPR biosensor

Ting Wang, Guo-Ling Wang, Jingli Han, Lixin Wu, Yuanyuan Zhang, Hai-Xia Fu, Jia Feng, Hongyu Zhang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 394.

https://doi.org/10.1182/blood-2025-394

Published: 2025

Journal Articles

Response to Hetrombopag Among patients with acute and persistent primary immune thrombocytopenia: A real-world study in China

Yimei Feng, Aoxue Tan, Jia Liu, Peiyan Kong, Xi Zhang

Blood (2025) 146 (Supplement 1): 4819.

https://doi.org/10.1182/blood-2025-4819

Published: 2025

Journal Articles

Longitudinal immune reconstitution dynamics in refractory T-ALL treated with CD7 CAR-T cells bridging to allogeneic stem cell transplantation

Guo-Ling Wang, Han-Peng Luo, Ting Wang, Hai-Chan Xu, Li-Hua Sun, Bao-Zhen Qin, Hongyu Zhang, Jia Feng, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3325.

https://doi.org/10.1182/blood-2025-3325

Published: 2025

Journal Articles

Mechanism and therapeutic efficacy of the XPO1 inhibitor selinexor in refractory/relapsed EBV-positive NK cell lymphoma

Yaxian Ma, Yuhan Bao, Min Liu, Tongjuan Li, Qing Yin, Zetong Hong, Yan Feng, Jia Wei, Miao Zheng

Blood (2025) 146 (Supplement 1): 7174.

https://doi.org/10.1182/blood-2025-7174

Published: 2025

Journal Articles

Efficacy and safety of Daratumumab in relapse/refractory diffuse large B-cell lymphoma

Zetong Hong, ZhaoYang Hong, Tongjuan Li, Yaxian Ma, Min Liu, Qing Yin, Wei Huang, Kuangguo Zhou, Dan Li, Yan Feng, Jia Wei, Miao Zheng

Blood (2025) 146 (Supplement 1): 7225.

https://doi.org/10.1182/blood-2025-7225

Published: 2025

Journal Articles

Efficacy of a venetoclax-based, anthracycline-free regimen in newly diagnosed CBFβ::MYH11(+) acute myeloid leukemia

Ziyu Feng, Jia Chen, Haiping Dai, Xiaohui Hu, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Han Yue, Suning Chen, Depei Wu, Ying Wang

Blood (2025) 146 (Supplement 1): 1674.

https://doi.org/10.1182/blood-2025-1674

Published: 2025

Journal Articles

A novel BCL-2 inhibitor, bda-366, targets the TLR4 pathway to induce leukemic cell differentiation in venetoclax-resistant RAS-mutated monocytic leukemia

Xiaohui Zhang, Lixin Wu, Ping Zhang, Jia Feng, Xiaojun Huang, Hongyu Zhang

Blood (2025) 146 (Supplement 1): 5054.

https://doi.org/10.1182/blood-2025-5054

Published: 2025

Journal Articles

Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study

Blood (2025) 146 (Supplement 1): 5818.

https://doi.org/10.1182/blood-2025-5818

Published: 2025

Journal Articles

Effect of the dominant-negative ikaros isoform 6 (Ik6) on cell function and drug sensitivity in acute lymphoblastic leukemia cell lines

Qishan Hao, Juan Feng, Meizhen Xu, Yanan Jia, Qiuyun Fang, Yan Li, Zheng Tian, Min Wang, Jianxiang Wang, Yingchang Mi

Blood (2025) 146 (Supplement 1): 6827.

https://doi.org/10.1182/blood-2025-6827

Published: 2025

Journal Articles

A dual targeting BCMA and CD19 fastcar-t (GC012F/AZD0120) as first-line therapy for newly diagnosed multiple myeloma

Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Nina Shah, Qi Zhang, Lianjun Shen, Jia Liu

Blood (2025) 146 (Supplement 1): 258.

https://doi.org/10.1182/blood-2025-258

Published: 2025

Journal Articles

Transfusion dependence is associated with poor survival in MDS-h and MDS-LB, while transplantation improves outcomes

Wenjing Guo, Linlin Liu, Li Jia, Hui Wang, Aiming Pang, Erlie Jiang, Zhijian Xiao, Sizhou Feng

Blood (2025) 146 (Supplement 1): 7381.

https://doi.org/10.1182/blood-2025-7381

Published: 2025

Journal Articles

Different graft-vs-host disease prophylaxis strategy for allogeneic hematopoietic stem cell transplantation in adults with chronic active EBV infection

Min Liu, Qiuxia Yu, Yang Cao, Jia Wei, Yaxian Ma, Zetong Hong, Qing Yin, Yan Feng, ZhaoYang Hong, Tongjuan Li, Jia Gu, Liting Chen, Yicheng Zhang, Miao Zheng

Blood (2025) 146 (Supplement 1): 7758.

https://doi.org/10.1182/blood-2025-7758

Published: 2025

Journal Articles

Allosteric inhibition of RAN decreases mir-126 biogenesis in endothelial cells and controls Acute Myeloid Leukemia growth

Melissa Valerio, Guido Marcucci, Le Xuan Truong Nguyen, Nagarajan Vaidehi, Wenyuan Wei, Hyunjun Kang, Ning Ma, Supriyo Bhattacharya, Genevieve Baker, Weidong Hu, Lianjun Zhang, Dinh Hoang Hoa, Bin Zhang, J. Jefferson Perry, Jia Feng, Hongyu Zhang

Blood (2025) 146 (Supplement 1): 3294.

https://doi.org/10.1182/blood-2025-3294

Published: 2025

Journal Articles

CRE intestinal colonization correlates with increased progression risk following CAR T cell therapy in relapsed/refractory lymphoma

Qing Yin, Yaxian Ma, Zetong Hong, Yan Feng, Min Liu, Tongjuan Li, Jia Wei, Miao Zheng

Blood (2025) 146 (Supplement 1): 1939.

https://doi.org/10.1182/blood-2025-1939

Published: 2025

Journal Articles

Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-t alone in relapsed/refractory large B-cell lymphoma

Jiaqi Li, Shanglong Feng, Ying Zhang, Yuchen Hua, Liqing Kang, Lei Yu, Jia Chen, Xiebin Bao, Ting Xu, Depei Wu, Caixia Li

Blood (2025) 146 (Supplement 1): 1933.

https://doi.org/10.1182/blood-2025-1933

Published: 2025

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

One-year follow-up of CD19/BCMA dual-targeting fastcar-T GC012F (AZD0120) therapy in patients with refractory systemic lupus erythematosus

Thyroid diffuse large B-cell lymphoma in China: Multicenter study of diagnosis, clinical features, treatment efficacy, prognostic factors, and genomic alterations

A phase 1 study of lucar-G39D: A novel anti-CD20/CD19 dual-CAR allogeneic gamma delta T cells in adults with relapsed / refractory B-cell non-Hodgkin lymphoma (NHL)

Discrimination of Epstein–Barr virus latent infection and lytic replication reactivation using a novel methyl-CRISPR biosensor

Response to Hetrombopag Among patients with acute and persistent primary immune thrombocytopenia: A real-world study in China

Longitudinal immune reconstitution dynamics in refractory T-ALL treated with CD7 CAR-T cells bridging to allogeneic stem cell transplantation

Mechanism and therapeutic efficacy of the XPO1 inhibitor selinexor in refractory/relapsed EBV-positive NK cell lymphoma

Efficacy and safety of Daratumumab in relapse/refractory diffuse large B-cell lymphoma

Efficacy of a venetoclax-based, anthracycline-free regimen in newly diagnosed CBFβ::MYH11(+) acute myeloid leukemia

A novel BCL-2 inhibitor, bda-366, targets the TLR4 pathway to induce leukemic cell differentiation in venetoclax-resistant RAS-mutated monocytic leukemia

Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study

Effect of the dominant-negative ikaros isoform 6 (Ik6) on cell function and drug sensitivity in acute lymphoblastic leukemia cell lines

A dual targeting BCMA and CD19 fastcar-t (GC012F/AZD0120) as first-line therapy for newly diagnosed multiple myeloma

Transfusion dependence is associated with poor survival in MDS-h and MDS-LB, while transplantation improves outcomes

Different graft-vs-host disease prophylaxis strategy for allogeneic hematopoietic stem cell transplantation in adults with chronic active EBV infection

Allosteric inhibition of RAN decreases mir-126 biogenesis in endothelial cells and controls Acute Myeloid Leukemia growth

CRE intestinal colonization correlates with increased progression risk following CAR T cell therapy in relapsed/refractory lymphoma

Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-t alone in relapsed/refractory large B-cell lymphoma

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only